These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27244931)

  • 1. [Immuno-oncology--silver bullets or mass destruction weapons?].
    Utriainen M; Rämet M
    Duodecim; 2016; 132(8):721-8. PubMed ID: 27244931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint modulation: rational design of combination strategies.
    Zamarin D; Postow MA
    Pharmacol Ther; 2015 Jun; 150():23-32. PubMed ID: 25583297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Senant M; Giusti D; Weiss L; Dragon-Durey MA
    Bull Cancer; 2016 Nov; 103 Suppl 1():S175-S185. PubMed ID: 28057182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulatory T cells in cancer immunotherapy].
    Nishikawa H
    Rinsho Ketsueki; 2014 Oct; 55(10):2183-9. PubMed ID: 25297785
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent developments and future challenges in immune checkpoint inhibitory cancer treatment.
    Koster BD; de Gruijl TD; van den Eertwegh AJ
    Curr Opin Oncol; 2015 Nov; 27(6):482-8. PubMed ID: 26352539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy.
    Brunner-Weinzierl MC; Rudd CE
    Front Immunol; 2018; 9():2737. PubMed ID: 30542345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations.
    Parchment RE; Voth AR; Doroshow JH; Berzofsky JA
    Semin Oncol; 2016 Aug; 43(4):501-13. PubMed ID: 27663482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitors for cancer treatment.
    Park J; Kwon M; Shin EC
    Arch Pharm Res; 2016 Nov; 39(11):1577-1587. PubMed ID: 27770382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy and gene therapy as novel treatments for cancer.
    Rangel-Sosa MM; Aguilar-Córdova E; Rojas-Martínez A
    Colomb Med (Cali); 2017 Sep; 48(3):138-147. PubMed ID: 29213157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dendritic cell and cancer immune checkpoint].
    Kubo T; Hirohashi Y; Torigoe T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(5):468-472. PubMed ID: 27795504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Part II: Checkpoint inhibitors in cancer therapy.
    Daud AI
    Immunotherapy; 2016 Jun; 8(7):761-2. PubMed ID: 27349974
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations.
    Hoos A
    Nat Rev Drug Discov; 2016 Apr; 15(4):235-47. PubMed ID: 26965203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?
    Kremer L; Garcia-Sanz JA
    Front Immunol; 2018; 9():442. PubMed ID: 29556241
    [No Abstract]   [Full Text] [Related]  

  • 14. Lessons from CTLA-4 deficiency and checkpoint inhibition.
    Lo B; Abdel-Motal UM
    Curr Opin Immunol; 2017 Dec; 49():14-19. PubMed ID: 28806575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1.
    Herrera-Camacho I; Anaya-Ruiz M; Perez-Santos M; Millán-Pérez Peña L; Bandala C; Landeta G
    Expert Opin Ther Pat; 2019 Aug; 29(8):587-593. PubMed ID: 31241380
    [No Abstract]   [Full Text] [Related]  

  • 16. IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to Immunotherapy.
    Chen JC; Perez-Lorenzo R; Saenger YM; Drake CG; Christiano AM
    Cell Syst; 2018 Jul; 7(1):92-103.e4. PubMed ID: 29960886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Releasing the Brakes on Cancer Immunotherapy.
    Littman DR
    Cell; 2015 Sep; 162(6):1186-90. PubMed ID: 26359975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy and immunotherapy: mapping the road ahead.
    Cook AM; Lesterhuis WJ; Nowak AK; Lake RA
    Curr Opin Immunol; 2016 Apr; 39():23-9. PubMed ID: 26724433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of checkpoints antibodies.
    Wang C; Ye Y; Gu Z
    Hum Vaccin Immunother; 2017 Jan; 13(1):245-248. PubMed ID: 27668759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor immunity and advances in cancer immunotherapy.
    Sugie T; Toi M
    Breast Cancer; 2017 Jan; 24(1):1-2. PubMed ID: 27882505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.